Johnson & Johnson (JNJ) Earnings (2008 - 2026)
Johnson & Johnson (JNJ) earnings from Jun 29, 2008 to Mar 29, 2026. The TTM Johnson & Johnson (JNJ) earnings is $21B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Johnson & Johnson (JNJ) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +127.78% |
| 3 Years TTM | +21.32% |
| 5 Years TTM | +29.15% |
| 10 Years TTM | +11.19% |
| All Time TTM | +7.18% |
Annual Earnings change of Johnson & Johnson (JNJ)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $5.24B | -80.47% |
| 2025 | $27B | +90.56% |
| 2024 | $14B | -59.99% |
| 2023 | $35B | +688.54% |
| 2022 | $4.46B | -69.70% |
| 2021 | $15B | +13.39% |
| 2020 | $13B | -14.17% |
| 2019 | $15B | -1.16% |
| 2018 | $15B | +1076.69% |
| 2017 | $1.30B | -69.57% |
| 2016 | $4.27B | +27.22% |
| 2015 | $3.36B | -79.43% |
| 2014 | $16B | +18.02% |
| 2013 | $14B | +27.44% |
| 2012 | $11B | +238.94% |
| 2011 | $3.20B | -6.29% |
| 2010 | $3.42B | +2.15% |
| 2009 | $3.35B | -74.17% |
| 2008 | $13B | +22.44% |
| 2007 | $11B | N/A |
Comparison Johnson & Johnson (JNJ) five years earnings CAGR with competitors
Johnson & Johnson (JNJ) five years earnings CAGR is 6.84%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| GILD | Gilead Sciences Inc | 98.24% | +1336.61% |
| LLY | Lilly(Eli) & Company | 32.92% | +381.38% |
| NVO | Novo Nordisk | 23.10% | +237.86% |
| AZN | Astrazeneca plc | 21.17% | +209.61% |
| NVS | Novartis AG | 11.21% | +63.97% |
| MRK | Merck & Co Inc | 4.92% | -28.03% |
| GSK | GSK Plc | 2.84% | -58.42% |
| AMGN | AMGEN Inc | 1.94% | -71.61% |